The 81st Annual Meeting of the Japanese Society of Hematology

japanese

Invited Speakers

Roy Silverstein Roy Silverstein
（Medicine Department, Medical College of Wisconsin, WI, USA）

ASH Special Lecture：
Platelet CD36 is at the intersection of inflammation and arterial thrombosis
Shai Izraeli Shai Izraeli
（Division of Pediatric Hematology and Oncology, Schneider Children's Medical Center of Israel, Israel）

EHA Special Lecture：
High risk JAK STAT driven acute lymphoblastic leukemia lessons from Down Syndrome
Malcolm K. Brenner Malcolm K. Brenner
（Center for Cell and Gene Therapy, Baylor College of Medicine, TX, USA）

Special Lecture 2：
Will cell therapy for hematological malignancy be a panacea?
Hugues de Thé Hugues de Thé
（Collège de France, Paris, France）

Special Lecture 3：
Acute promyelocytic leukemia cure by retinoic acid and arsenic
Robert Kralovics Robert Kralovics
（Laboratory Medicine, Medical University of Vienna, Austria）

Presidential Symposium 2：
Genetic causes of myeloproliferative diseases and new therapeutic targets
Alessandro Vannucchi Alessandro Vannucchi
（CRIMM, AOU CAREGGI,　University of Florence, Firenze, Italy）

Presidential Symposium 2：
CURRENT MANAGEMENT OF ESSENTIAL THROMBOCYTHEMIA IN YOUNG SUBJECTS
Jean-Jacques Kiladjian Jean-Jacques Kiladjian
（Clinical Investigations Center, Saint-Louis Hospital, France）

Presidential Symposium 2：
Interferon alpha (IFNa) renaissance in myeloproliferative neoplasms (MPN)
Ruben A. Mesa Ruben A. Mesa
（The UT Health San Antonio MD Anderson Cancer Center, TX, USA）

Presidential Symposium 2：
MPN Disease Burden: Lessons Learned from MPN Patients
Siddhartha Jaiswal Siddhartha Jaiswal
（Pathology, Stanford University, CA, USA）

Symposium 1：
Clonal hematopoiesis in human aging and disease
Marc H.G.P.　Raaijmakers Marc H.G.P.　Raaijmakers
（Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands）

Symposium 1：
Microenvironmental contributions to bone marrow failure and clonal evolution
Dorine W. Swinkels Dorine W. Swinkels
（Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, Netherlands）

Symposium 2：
Iron Refractory Iron Deficiency Anemia: Pathophysiology and Clinical Management
Stephen P. Hunger Stephen P. Hunger
（Pediatric Oncology, Children’s Hospital of Philadelphia, PA, USA）

Symposium 3：
Testing Novel and Targeted Therapies in Children， Adolescents and Young Adults with ALL
Jean Soulier Jean Soulier
（Saint-Louis Hospital and University of Paris, France）

Symposium 5：
Inherited bone marrow failure
Marcin Wlodarski Marcin Wlodarski
（St. Jude Children’s Research Hospital, Memphis, TN, USA）

Symposium 5：
Clinical and Genetic Heterogeneity of GATA2 and SAMD9/9L Syndromes Predisposing to MDS
Michael Boeckh Michael Boeckh
（Dept of Allergy and Infectious Diseases, Fred Hutchinson Cancer Research Center and University of Washington, USA）

Symposium 6：
Respiratory Viral Infections after Hematopoietic Cell Transplantation: Challenges and Opportunities
Robert Zeiser Robert Zeiser
（Hematology, Oncology and Stem Cell Transplantation, University Hospital Freiburg, Freiburg im Breisgau, Germany）

Symposium 6：
Novel findings in GVHD
Gerrit J. Schuurhuis Gerrit J. Schuurhuis
（VU University Medical Center, Amsterdam, Netherlands）

Symposium 7 [JSH-EHA Joint Symposium]：
Measurable/Residual Disease (MRD) in AML. Recommendations from European LeukemiaNet with the role of flow cytometry in (stem cell) MRD and its relation to molecular approaches
Robert K. Hills Robert K. Hills
（Nuffield Department of Population Health, University of Oxford, UK）

Symposium 7 [JSH-EHA Joint Symposium]：
Assessment of MRD in standard-risk AML
David Weinstock David Weinstock
（Dana-Farber Cancer Institute and Harvard Medical School, USA）

Symposium 8 [JSH-ASH Joint Symposium]：
Novel Therapeutics for Lymphoid Malignancies
Kerry J. Savage Kerry J. Savage
（British Columbia Cancer Agency, Canada）

Symposium 8 [JSH-ASH Joint Symposium]：
Update on secondary CNS relapse in diffuse large B-cell lymphoma: Who is ‘high risk’? Optimal prophylaxis?
Alexander Lesokhin Alexander Lesokhin
（Memorial Sloan Kettering Cancer Center, NY, USA）

Symposium 9：
Progress and Challenges for Immune Checkpoint blockade in Hematologic Malignancies
Catherine Wu Catherine Wu
（Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, MA, USA）

Symposium 9：
Developing personalized cancer vaccines
James N. Kochenderfer James N. Kochenderfer
（Experimental Transplantation and Immunology Dept., National Cancer Institute, NIH, MD, USA）

Symposium 10：
B-cell maturation antigen (BCMA) as a therapeutic target of chimeric antigen receptor T cells.
Dirk Hose Dirk Hose
（Universitatsklinikum Heidelberg, Ruprecht-Karls-Universität Heidelberg, Germany）

Symposium 10：
Targeting B-cell maturation antigen with T-cell bispecific antibodies for the treatment of malignant plasma cell dyscrasias - preclinical and clinical development of EM801
Noopur Raje Noopur Raje
（Cancer Center, Massachusetts General Hospital, Boston, Massachusetts）

Educational Lecture EL1-2B：
Current management and emergine treatment strategies for multiple myeloma
John Leonard John Leonard
（Department of Medicine, Weill Cornell Medicine, USA）

Educational Lecture EL1-2F：
New developments in the treatment of follicular lymphoma
Hans-Michael Kvasnicka Hans-Michael Kvasnicka
（Helios University Clinic Wuppertal University of Witten/Herdecke, Germany）

Educational Lecture EL3-4B：
The differential diagnosis of classical myeloproliferative neoplasms (MPN): the updated WHO criteria
Srdan Verstovsek Srdan Verstovsek
（Leukemia Dept., The University of Texas MD Anderson Cancer Center, USA）

Educational Lecture EL3-4C：
Novel treatment strategy for myeloproliferative neoplasms
Zhijian Xiao Zhijian Xiao
（Institute of Hematology, Chinese Academy of Medical Sciences, China）

Asian Joint Panel Discussion：
Unique clinical and laboratory characteristics in Chinese PM
Chien-Chin Lin Chien-Chin Lin
（Attending Physician, Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan）

Asian Joint Panel Discussion：
Primary Myelofibrosis in Taiwan: Clinical Manifestation， Translational Research， and Current Treatment.
Pongtep Viboonjuntra Pongtep Viboonjuntra
（Division of Hematology, Department of Medicine, Faculty of Medicine, Prince Songkla University, Thailand）

Asian Joint Panel Discussion：
Impact of Colony Assay on the Clinical Characteristics of Polycythemia Vera， Essential Thrombocythemia and Primary Myelofibrosis， The Experience in Songklanagarind Hospital
Junshik Hong Junshik Hong
（Seoul National University Hospital, Korea）

Asian Joint Panel Discussion：
Risk of Disease Transformation and Second Primary Solid Tumors in Korean Patients with Myeloproliferative Neoplasms
Rabindra Kumar Jena Rabindra Kumar Jena
（Dept of Clinical Haematology, SCB Medical College & Hospital, India）

Asian Joint Panel Discussion：
Epidemiology， Diagnosis and Treatment of Myeloproliferative Neoplasms in India
Kiat Hoe Ong Kiat Hoe Ong
（Tang Tok Seng Hospital, Singapore）

Asian Joint Panel Discussion：
Use of interferon in MPN treatment in Singapore
▲ Page Top
Copyright © The 81st Annual Meeting of the Japanese Society of Hematology All Rights Reserved.